Literature DB >> 17032985

Translation of research evidence from animals to humans.

Daniel G Hackam, Donald A Redelmeier.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17032985     DOI： 10.1001/jama.296.14.1731

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  225 in total

1.  Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

Review 2.  Liver metastases: Microenvironments and ex-vivo models.

Authors:  Amanda M Clark; Bo Ma; D Lansing Taylor; Linda Griffith; Alan Wells
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

3.  Translating animal research into clinical benefit.

Authors:  Daniel G Hackam
Journal:  BMJ       Date:  2007-01-27

Review 4.  Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.

Authors:  Victoria E O'Collins; Malcolm R Macleod; Susan F Cox; Leena Van Raay; Elena Aleksoska; Geoffrey A Donnan; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-27       Impact factor: 6.200

5.  Comment on 'The ethics of animal research' by Festing & Wilkinson.

Authors:  Kathy Archibald; Margaret Clotworthy
Journal:  EMBO Rep       Date:  2007-09       Impact factor: 8.807

6.  Why animal studies are often poor predictors of human reactions to exposure.

Authors:  Michael B Bracken
Journal:  J R Soc Med       Date:  2009-03       Impact factor: 5.344

Review 7.  Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Authors:  Claire T Deakin; Ian E Alexander; Ian Kerridge
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

Review 8.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

9.  A call for transparent reporting to optimize the predictive value of preclinical research.

Authors:  Story C Landis; Susan G Amara; Khusru Asadullah; Chris P Austin; Robi Blumenstein; Eileen W Bradley; Ronald G Crystal; Robert B Darnell; Robert J Ferrante; Howard Fillit; Robert Finkelstein; Marc Fisher; Howard E Gendelman; Robert M Golub; John L Goudreau; Robert A Gross; Amelie K Gubitz; Sharon E Hesterlee; David W Howells; John Huguenard; Katrina Kelner; Walter Koroshetz; Dimitri Krainc; Stanley E Lazic; Michael S Levine; Malcolm R Macleod; John M McCall; Richard T Moxley; Kalyani Narasimhan; Linda J Noble; Steve Perrin; John D Porter; Oswald Steward; Ellis Unger; Ursula Utz; Shai D Silberberg
Journal:  Nature       Date:  2012-10-11       Impact factor: 49.962

10.  A critical examination of best dose analysis for determining cognitive-enhancing potential of drugs: studies with rhesus monkeys and computer simulations.

Authors:  Paul L Soto; Jesse Dallery; Nancy A Ator; Brian R Katz
Journal:  Psychopharmacology (Berl)       Date:  2013-03-26       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.